SAN FRANCISCO, Sept. 2, 2025 /PRNewswire/ -- A securities fraud class action lawsuit styled Liggett Sr. v. C3.ai, Inc., et al., No. 3:25-cv-07129 (N.D. Cal.) has been filed and seeks to represent C3.ai (NYSE: AI) investors who purchased or otherwise acquired C3.ai securities between February 26, 2025 and August 8, 2025.The lawsuit comes after C3.ai reported preliminary financial results for its Q1 2026, which shockingly included expected revenues between only $70.2 million-$70.4 million, well below the midp ...

Key Takeaways AI expects Q1 revenue of $70.2M-$70.4M, down 19% year over year and well below prior guidance.Non-GAAP Q1 operating loss is estimated to be $57.7M-$57.9M, reflecting deepening financial strain.AI's partner-driven strategy shows promise, with 73% of Q4 deals involving channel partners.C3.ai, Inc. (AI) is scheduled to report its first-quarter of fiscal 2026 results on Sept. 3, after the closing bell.In the last reported quarter, C3.ai’s top and bottom lines surpassed the Zacks Consensus Estimate ...

Core Viewpoint - The C3.ai class action lawsuit alleges that the company and its executives misled investors regarding the company's revenue outlook and growth potential, particularly in relation to CEO Thomas M. Siebel's health concerns, which ultimately led to a significant drop in stock price following disappointing financial results [1][4][5]. Group 1: Lawsuit Details - The lawsuit is titled Liggett v. C3.ai, Inc. and is filed in the Northern District of California, seeking to represent purchasers of C3.ai securities [1]. - The complaint claims that C3.ai's optimistic growth reports were misleading and overly reliant on the health of its CEO [4]. - Following the announcement of disappointing preliminary financial results for Q1 FY 2026 and a reduction in revenue guidance, C3.ai's stock price fell by more than 25% [5]. Group 2: Legal Process - Investors who suffered losses and wish to serve as lead plaintiff must file motions by October 21, 2025 [2][6]. - The lead plaintiff is typically the investor with the greatest financial interest and acts on behalf of all class members [6]. Group 3: Company Background - C3.ai operates as an enterprise artificial intelligence application software company [3]. - Robbins Geller Rudman & Dowd LLP, the law firm handling the case, is recognized for its success in securities fraud litigation, having recovered over $2.5 billion for investors in 2024 alone [7].

Core Viewpoint - A securities fraud class action lawsuit has been filed against C3.ai, Inc. for alleged misrepresentations regarding the company's business and the impact of the CEO's health on its operations [3][4]. Group 1: Lawsuit Details - The lawsuit was initiated in the United States District Court for the Northern District of California on behalf of investors who acquired C3 securities between February 26, 2025, and August 8, 2025 [3]. - Allegations include that the CEO's health significantly affected C3 AI's ability to close deals and that management failed to mitigate this impact, hindering the company's profit and growth potential [4]. Group 2: Legal Participation - Investors wishing to serve as lead plaintiffs must file necessary documents by October 21, 2025, although participation as a lead plaintiff is not required to share in any potential recovery [5]. - All legal representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [5]. Group 3: Law Firm Background - Bernstein Liebhard LLP, the law firm handling the case, has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [6]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [6].

NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in C3.ai, Inc. ("C3.ai" or the "Company") (NYSE: AI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of C3.ai investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 8, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/c3-ai-inc-lawsuit-submission-form?prid=164168 ...

Core Viewpoint - A class action lawsuit has been filed against C3.ai, Inc. for alleged violations of federal securities laws during the specified class period [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased C3.ai securities between February 26, 2025, and August 8, 2025 [2]. - The Complaint alleges that C3.ai's CEO's health significantly impaired the company's ability to close deals and that management was ineffective in mitigating this impact [3]. - As a result of these issues, C3.ai's potential for profit and growth was reportedly compromised [3]. Group 2: Next Steps for Investors - Investors who suffered losses in C3.ai have until October 21, 2025, to request to be appointed as lead plaintiff in the case [4]. - Participation in any recovery does not require serving as lead plaintiff [4]. Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning they will only collect fees if the case is successful [5]. - The firm has a history of recovering hundreds of millions of dollars for investors in securities fraud class actions [6].

Core Insights - C3.ai has experienced a significant decline in stock value, dropping 50% in 2025, with a notable loss of over 25% in a single day following the announcement of preliminary fiscal Q1 results [1][2] - The company's preliminary revenue for the last quarter was just over $70 million, falling short of the guidance range of $100 million to $109 million, and the non-GAAP operating loss was nearly $58 million, more than double the initial expectation [5][6] - C3.ai's performance has deteriorated compared to the previous year, where it reported $87 million in revenue and a non-GAAP operating loss of $16.6 million [6] Company Performance - C3.ai provides an AI software platform for enterprise and federal customers, and has been expanding its customer base, indicating potential in the enterprise AI software market [4] - The recent poor performance is attributed to organizational restructuring and leadership changes, which have had a disruptive effect on operations [8][9] - The CEO's health issues have also impacted the sales process, contributing to the company's underperformance [8] Future Outlook - C3.ai is currently searching for a new CEO, which may further affect its performance during the transition period [9] - The company has announced a new contract with Brazil's Eletrobras and launched new AI solutions, which could stabilize its operations in the future [11] - Despite the challenges, the AI software market is projected to grow at a compound annual rate of 25% through 2030, presenting potential opportunities for C3.ai if it can navigate its current issues effectively [13]

Group 1 - The C3.ai class action lawsuit, titled Liggett v. C3.ai, Inc., seeks to represent purchasers of C3.ai securities and alleges violations of the Securities Exchange Act of 1934 by C3.ai and its executives [1] - The lawsuit claims that C3.ai misrepresented its revenue outlook and growth potential while downplaying risks associated with CEO Thomas M. Siebel's health [4] - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 FY 2026 and reduced its revenue guidance for the full fiscal year, leading to a stock price drop of over 25% [5] Group 2 - The lead plaintiff process allows any investor who purchased C3.ai securities during the Class Period to seek appointment as lead plaintiff, representing the interests of the class [6] - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [7]

Core Viewpoint - A securities class action lawsuit has been filed against C3.ai, Inc. for failing to disclose material information during the class period, leading to significant financial losses for investors [3][4]. Group 1: Lawsuit Details - Investors have until October 21, 2025, to file lead plaintiff applications in the lawsuit against C3.ai, Inc. for securities purchased between February 26, 2025, and August 8, 2025 [1][2]. - The lawsuit alleges that C3 and certain executives violated federal securities laws by not disclosing critical information during the class period [3]. - On August 8, 2025, C3 disclosed disappointing preliminary financial results for Q1 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing the poor performance to a reorganization and health issues of the CEO [3]. Group 2: Financial Impact - Following the announcement of the disappointing results, C3's share price dropped from $22.13 on August 8, 2025, to $16.47 on August 11, 2025, marking a decline of approximately 25.58% [4]. Group 3: Legal Representation - Kahn Swick & Foti, LLC, a prominent securities litigation law firm, is representing the investors in this case, with a strong track record in recovering investment losses due to corporate fraud [4].

Core Insights - C3.ai, Inc. is emphasizing its partner ecosystem as a crucial growth driver, with 73% of agreements in fiscal 2025 completed through partnerships, marking a 68% increase from the previous year [1][9] - The company reported a significant rise in partner-supported bookings, which surged 419% year over year in the fiscal fourth quarter, with 59 agreements signed through collaborations [1] Partnerships and Collaborations - The partnership with Microsoft is pivotal, resulting in 28 new agreements in the fiscal fourth quarter, particularly in manufacturing and chemicals [2] - Collaborations with Google Cloud and Amazon's AWS are also enhancing market reach and delivery capabilities [2] - New advisory alliances with McKinsey QuantumBlack and PwC are broadening distribution capacity and targeting key industries [3][4] Market Performance and Valuation - C3.ai shares have declined by 25.8% over the past year, compared to a 9.5% decline in the industry [7] - The company trades at a forward price-to-sales ratio of 5.58X, significantly lower than the industry average of 17.49X [8] - The Zacks Consensus Estimate for fiscal 2026 earnings per share indicates a year-over-year decline of 239%, while fiscal 2027 shows a projected increase of 65.9% [11]